Integrated solutions tailored for Israel's leading clinical research organizations and medical startups.
As the "Start-up Nation," Israel has solidified its position as a global epicenter for life sciences, biotechnology, and medical device innovation. With over 1,500 active life science companies and world-renowned institutions like the Sheba Medical Center and Weizmann Institute of Science, the demand for sophisticated Clinical Research Data Management Solutions has reached an all-time high. The transition from traditional, site-centric paper trials to Decentralized Clinical Trials (DCT) and remote patient monitoring requires a robust hardware-software bridge.
Dongguan Trial Medical Co., Ltd. serves this vibrant market by providing the physical infrastructure and integrated digital tools necessary to capture, process, and secure clinical data. Whether it's wearable sensors for real-time monitoring or high-precision lab automation components, our manufacturing expertise in Dongguan enables Israeli innovators to scale from prototype to global clinical trials with unparalleled efficiency.
The global clinical trials market is projected to grow at a CAGR of 5.8%, driven largely by the push for personalized medicine and digital health. However, the bottleneck often lies in hardware manufacturing speed and data interoperability. This is where Trial Medical's presence in Dongguan—the "World's Factory"—provides a strategic advantage for Israeli partners.
Our facility integrates Comprehensive CNC Machining, medical-grade sterilization systems, and IoT connectivity modules under one roof. For an Israeli med-tech startup, this means reduced lead times, strict adherence to international safety standards (FDA, CE), and the ability to customize OEM solutions for specific patient demographics in the Middle East and beyond.
Implementing remote clinical trial monitoring devices for patients residing in urban Tel Aviv, ensuring high retention through user-friendly wearable data collection systems.
Utilizing precision robotic components and advanced sterilization systems to automate sample processing in high-throughput genetic research facilities.
Applying ICG API integration to ensure all captured health data complies with both Israel's Privacy Protection Regulations and international GDPR/HIPAA standards.
Dongguan Trial Medical Co., Ltd. is a specialized manufacturer of remote clinical trial monitoring devices, decentralized clinical trial solutions, and digital research technologies. Established in 2016, the company is located in Dongguan, China, a major center for advanced manufacturing, medical technology development, and electronic innovation.
Operating from a modern facility covering more than 11,000 square meters, with a team of over 230 employees, Trial Medical is dedicated to developing and manufacturing innovative technologies that support clinical research organizations, pharmaceutical companies, healthcare institutions, and academic research centers worldwide.
The company's product portfolio includes remote clinical trial monitoring devices, wearable health data collection systems, patient engagement platforms, electronic clinical outcome assessment solutions, digital research tools, remote safety monitoring systems, and decentralized trial support technologies. These solutions are designed to facilitate real-time data collection, improve participant engagement, streamline study management, and enhance operational efficiency throughout the clinical research process.
The industry is moving toward "Information Gain" where raw data is instantly transformed into actionable insights. Key trends include:
Comprehensive hardware solutions for ensuring data integrity and biological safety.
Our solutions are designed with high-level encryption and API flexibility, allowing for seamless integration with the advanced digital health records used by Israeli HMOs (Clalit, Maccabi) and strict compliance with the Israel Ministry of Health requirements.
Yes. We specialize in ODM/OEM services where we can take a prototype design from an Israeli startup and optimize it for mass manufacturing in our Dongguan facility, ensuring medical-grade quality and cost-efficiency.
We use a multi-layered approach: hardware-level data verification, secure cloud transmission via our integrated ICG API, and real-time monitoring of device health to prevent data loss or corruption during clinical studies.
All our autoclaves and sterilization systems are built to meet international standards including ISO 13485, CE certification, and are suitable for use in high-stakes clinical research environments worldwide.